Thursday, November 30, 2023
Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships.
Associate Professor
University of Milan
Director, Head and Neck Medical Oncology Unit
Fondazione IRCCS Istituto Nazionale dei Tumori Milano
Milan, Italy
This activity has been peer reviewed and the reviewer has no relevant financial relationships.
Physicians - maximum of 1.00 AMA PRA Category 1 Credit(s)™
ABIM Diplomates - maximum of 1.00 ABIM MOC points
This educational activity is intended for oncologists, surgeons, pathologists and other members of the oncology care team managing patients with recurrent/metastatic squamous cell carcinoma of the head and neck (SCCHN) outside of the United States.
The goal of this activity is for learners to be better able to identify patients with recurrent/metastatic SCCHN who are eligible for systemic therapy and to select first-line therapy based upon current clinical guideline recommendations.
Upon completion of this activity, participants will:
Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships.
Associate Professor
University of Milan
Director, Head and Neck Medical Oncology Unit
Fondazione IRCCS Istituto Nazionale dei Tumori Milano
Milan, Italy
This activity has been peer reviewed and the reviewer has no relevant financial relationships.
Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons of Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME’s “CME in Support of MOC” program in Section 3 of the Royal College’s MOC Program.
For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]
There are no fees for participating in or receiving credit for this online educational activity. For information on applicability
and acceptance of continuing education credit for this activity, please consult your professional licensing board.
This activity is designed to be completed within the time designated on the title page; physicians should claim only those
credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the
activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.
Follow these steps to earn CME/CE credit*:
You may now view or print the certificate from your CME/CE Tracker. You may print the certificate, but you cannot alter it.
Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period, you can print
out the tally as well as the certificates from the CME/CE Tracker.
*The credit that you receive is based on your user profile.
CME / ABIM MOC Released: 6/27/2023
Valid for credit through: 6/27/2024, 11:59 PM EST
processing....
The following cases are modeled on the interactive grand rounds approach. The questions within the activity are designed to test your current knowledge. After each question, you will be able to see whether you answered correctly and read evidence-based information that supports the most appropriate answer choice. The questions are designed to challenge you; you will not be penalized for answering the questions incorrectly. At the end of the activity, there will be a short post-test assessment based on the material presented.
 |
Martin is a 60-year-old married, white male who is a non-smoker with a previous diagnosis of locally advanced (stage III) squamous cell carcinoma (SCC) of the supraglottic larynx. He has no notable prior medical history. He was initially treated with primary surgery followed by adjuvant radiation therapy. Two years later he presented with recurrent disease observed on a follow-up computerized tomography (CT).
Martin’s Workup
|
Physical Examination |
|
|
Laboratory Values |
|
|
CT Scan |
CT scan additionally reveals 8 bilateral lung nodules that are concerning for recurrence (lesions measure 1 to 2 cm) |
|
Cytology of Supraclavicular Lymph Node Biopsy |
Confirms SCC lung metastases |
BP, blood pressure; HR, heart rate; ECOG PS, Eastern Cooperative Oncology Group Performance Status; WBC, white blood cell.
